An amendment to an offering — the company changed its terms or corrected its filing.

iMetabolic Biopharma Corp

iMetabolic Biopharma Corp filed a Form C/A — amendment — with the SEC on Apr 24, 2023. The Regulation Crowdfunding offering seeks $10,000, up to a maximum of $1,230,000 on StartEngine. Investors receive: Other. The offering closes Jun 7, 2023.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.